Consolidated and emerging inflammatory markers in coronary artery disease.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  World Journal of Experimental Medicine

• Publication date

  2015-02-20

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.5493/wjem.v5.i1.21PMID 25699231PMCID PMC4308529
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Anti-inflammatory therapies for cardiovascular disease.

  2014cited by this paper
• Serum Amyloid A as a Marker of Persistent Inflammation and an Indicator of Cardiovascular and Renal Involvement in Patients with Rheumatoid Arthritis

  2014cited by this paper
• Gender-specific correlation between plasma myeloperoxidase levels and serum high-density lipoprotein-associated paraoxonase-1 levels in patients with stable and unstable coronary artery disease.

  2013cited by this paper
• Biomarkers for early detection of risk in female patients with coronary artery disease: pilot study.

  2013cited by this paper
• Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul Study.

  2012cited by this paper
• Prospective evaluation of pregnancy-associated plasma protein-a and outcomes in patients with acute coronary syndromes.

  2012cited by this paper
• Markers of plaque instability in the early diagnosis and risk stratification of acute myocardial infarction.

  2012cited by this paper
• Inflammation in Atherosclerosis

  2012cited by this paper
• C-reactive protein, fibrinogen, and cardiovascular disease prediction.

  2012cited by this paper
• Regulation of MicroRNA-155 in Atherosclerotic Inflammatory Responses by Targeting MAP3K10

  2012cited by this paper
• Comparative diagnostic accuracy of serum levels of neutrophil activating peptide-2 and pentraxin-3 versus troponin-I in acute coronary syndrome.

  2011cited by this paper
• Prospective study of circulating soluble CD40 ligand concentrations and the incidence of cardiovascular disease in a nested prospective case–control study of older men and women

  2011cited by this paper
• Elevated concentrations of pentraxin 3 are associated with coronary plaque vulnerability.

  2011cited by this paper
• Assessing the Role of Circulating, Genetic, and Imaging Biomarkers in Cardiovascular Risk Prediction

  2011cited by this paper
• Osteocalcin positive mononuclear cells are associated with the severity of aortic calcification.

  2010cited by this paper
• Pentraxin 3 as a Novel Marker Predicting Congestive Heart Failure in Subjects With Acute Coronary Syndrome

  2010cited by this paper
• 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

  2010cited by this paper
• Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans.

  2010cited by this paper
• ACCF/AHA Practice Guideline Practice Guidelines 2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults

  2010cited by this paper
• LOX index, a novel predictive biochemical marker for coronary heart disease and stroke.

  2010cited by this paper
• Pregnancy-associated plasma protein-A, a marker for outcome in patients suspected for acute coronary syndrome.

  2010cited by this paper
• The long pentraxin PTX3: a modulator of the immunoinflammatory response in atherosclerosis and cardiovascular diseases.

  2010cited by this paper
• Plasma microRNA 499 as a biomarker of acute myocardial infarction.

  2010cited by this paper
• Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction.

  2010cited by this paper
• Cholesterol Crystals Activate the NLRP3 Inflammasome in Human Macrophages: A Novel Link between Cholesterol Metabolism and Inflammation

  2010cited by this paper
• 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

  2010cited by this paper
• Soluble lectin-like oxidized low-density lipoprotein receptor-1 predicts prognosis after acute coronary syndrome--a pilot study.

  2010cited by this paper
• Circulating MicroRNAs in Patients With Coronary Artery Disease

  2010cited by this paper
• Deficiency of the Long Pentraxin PTX3 Promotes Vascular Inflammation and Atherosclerosis

  2009cited by this paper
• Association of serum glycated albumin, C-reactive protein and ICAM-1 levels with diffuse coronary artery disease in patients with type 2 diabetes mellitus.

  2009cited by this paper
• C-reactive protein: eighty years from discovery to emergence as a major risk marker for cardiovascular disease.

  2009cited by this paper
• National Academy of Clinical Biochemistry Laboratory Medicine Practice guidelines: emerging biomarkers for primary prevention of cardiovascular disease.

  2009cited by this paper
• Canadian Cardiovascular Society / Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult – 2009 recommendations

  2009cited by this paper
• Abstract 5171: High Levels of Myeloid-related Protein 14 in Human Atherosclerotic Plaques Correlate With the Characteristics of Rupture-prone Lesions

  2009cited by this paper
• Serum soluble lectin-like oxidized low-density lipoprotein receptor-1 correlates with oxidative stress markers in stable coronary artery disease.

  2009cited by this paper
• Complement Factor H Binds at Two Independent Sites to C-reactive Protein in Acute Phase Concentrations*♦

  2009cited by this paper
• C-reactive protein at the interface between innate immunity and inflammation

  2008cited by this paper
• Serum amyloid A as a marker and mediator of acute coronary syndromes.

  2008cited by this paper
• Cardioprotective Function of the Long Pentraxin PTX3 in Acute Myocardial Infarction

  2008cited by this paper
• Relation between plasma adiponectin, high-sensitivity C-reactive protein, and coronary plaque components in patients with acute coronary syndrome.

  2008cited by this paper
• Vascular calcification: pathobiology of a multifaceted disease.

  2008cited by this paper
• Interleukin-8 as an independent predictor of long-term clinical outcome in patients with coronary artery disease.

  2008cited by this paper
• Circulating Levels of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 are Associated with Inflammatory Markers

  2008cited by this paper
• Lectin-like oxidized LDL receptor-1 as extracellular chaperone receptor: its versatile functions and human diseases.

  2007cited by this paper
• Clinical application of C-reactive protein across the spectrum of acute coronary syndromes.

  2007cited by this paper
• Osteopontin: A Multifunctional Molecule Regulating Chronic Inflammation and Vascular Disease

  2007cited by this paper
• Evaluation of the association between the first observation and the longitudinal change in C-reactive protein, and all-cause mortality

  2007cited by this paper
• Serum amyloid A is a better predictor of clinical outcomes than C-reactive protein in non-ST-segment elevation acute coronary syndromes.

  2007cited by this paper
• Serum C-reactive protein as a marker for wellness assessment.

  2006cited by this paper
• Enhanced T-Cell Expression of RANK Ligand in Acute Coronary Syndrome: Possible Role in Plaque Destabilization

  2006cited by this paper
• Fibrinogen as a predictor of mortality after acute myocardial infarction: a forty-two-month follow-up study.

  2005cited by this paper
• Usefulness of high‐sensitivity IL‐6 measurement for clinical characterization of patients with coronary artery disease

  2005cited by this paper
• Serum Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Levels Are Elevated in Acute Coronary Syndrome: A Novel Marker for Early Diagnosis

  2005cited by this paper
• Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women.

  2005cited by this paper
• Human Microvascular Endothelial Cell Activation by IL‐1 and TNF‐α Stimulates the Adhesion and Transendothelial Migration of Circulating Human CD14+ Monocytes That Develop With RANKL Into Functional Osteoclasts

  2005cited by this paper
• ATVB in Focus Redox Mechanisms in Blood Vessels

  2005cited by this paper
• Prognostic value of serum amyloid A protein in patients with acute myocardial infarction.

  2005cited by this paper
• Adipokines: molecular links between obesity and atheroslcerosis.

  2005cited by this paper
• Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility.

  2005cited by this paper
• Associations between C‐reactive protein and circulating cell adhesion molecules in patients with unstable angina undergoing coronary intervention and their clinical implication

  2005cited by this paper
• Dysregulated Osteoprotegerin/RANK Ligand/RANK Axis in Clinical and Experimental Heart Failure

  2005cited by this paper
• Expression and function of RANK in human monocyte chemotaxis.

  2004cited by this paper
• Serum Amyloid A as a Predictor of Coronary Artery Disease and Cardiovascular Outcome in Women: The National Heart, Lung, and Blood Institute–Sponsored Women’s Ischemia Syndrome Evaluation (WISE)

  2004cited by this paper
• Prognostic Significance of the Long Pentraxin PTX3 in Acute Myocardial Infarction

  2004cited by this paper
• Biomarkers of cardiac disease

  2004cited by this paper
• Chemokines in the pathogenesis of vascular disease.

  2004cited by this paper
• Inflammatory cytokines and postmyocardial infarction remodeling.

  2004cited by this paper
• C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease.

  2004cited by this paper
• Role and importance of biochemical markers in clinical cardiology.

  2004cited by this paper
• Future of Biomarkers in Acute Coronary Syndromes Moving Toward a Multimarker Strategy

  2003cited by this paper
• Soluble CD40L: Risk Prediction After Acute Coronary Syndromes

  2003cited by this paper
• Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.

  2003cited by this paper
• Lack of Interleukin-1&bgr; Decreases the Severity of Atherosclerosis in ApoE-Deficient Mice

  2003cited by this paper
• Monocyte chemoattractant protein-1 concentration in coronary sinus blood and severity of coronary disease.

  2003cited by this paper
• Inflammatory markers and cardiovascular disease (The Health, Aging and Body Composition [Health ABC] Study).

  2003cited by this paper
• C-reactive protein: a critical update.

  2003cited by this paper
• Fibrinogen - marker or mediator of vascular disease?

  2003cited by this paper
• Association Between Plasma Levels of Monocyte Chemoattractant Protein-1 and Long-Term Clinical Outcomes in Patients With Acute Coronary Syndromes

  2003cited by this paper
• Serum Level of the Antiinflammatory Cytokine Interleukin-10 Is an Important Prognostic Determinant in Patients With Acute Coronary Syndromes

  2003cited by this paper
• Myeloperoxidase Serum Levels Predict Risk in Patients With Acute Coronary Syndromes

  2003cited by this paper
• Adhesion molecules and atherosclerosis.

  2003cited by this paper
• Innate and Adaptive Immunity in the Pathogenesis of Atherosclerosis

  2002cited by this paper
• Elevated soluble P-selectin levels are associated with an increased risk of early adverse events in patients with presumed myocardial ischemia.

  2002cited by this paper
• Association of C-reactive protein and serum amyloid A with recurrent coronary events in stable patients after healing of acute myocardial infarction.

  2002cited by this paper
• Production of the Long Pentraxin PTX3 in Advanced Atherosclerotic Plaques

  2002cited by this paper
• The effect of 17 beta-estradiol on MCP-1 serum levels in postmenopausal women.

  2002cited by this paper
• Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events*

  2002cited by this paper
• The effect of 17β-estradiol on MCP-1 serum levels in postmenopausal women

  2002cited by this paper
• Inflammation in atherosclerosis

  2002cited by this paper
• Circulating levels of ICAM-1, VCAM-1, and MCP-1 are increased in haemodialysis patients: association with inflammation, dyslipidaemia, and vascular events.

  2002cited by this paper
• Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events.

  2002cited by this paper
• Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy.

  2001cited by this paper
• Circulating Cell Adhesion Molecules and Death in Patients With Coronary Artery Disease

  2001cited by this paper
• Risk stratification in unstable angina and non-Q wave myocardial infarction using soluble cell adhesion molecules

  2001cited by this paper
• Soluble P-Selectin and the Risk of Future Cardiovascular Events

  2001cited by this paper
• Upregulation of CD40 and CD40 Ligand (CD154) in Patients With Moderate Hypercholesterolemia

  2001cited by this paper
• CD40 Signaling and Plaque Instability

  2001cited by this paper
• Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability.

  2000cited by this paper
• Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction.

  2000cited by this paper
• Evidence of prolonged inflammation in unstable angina and non-Q wave myocardial infarction.

  2000cited by this paper

• Bidirectional interplay between periodontal disease and carotid artery disease: a comprehensive holistic review

  2026cites this paper
• Inflammation Beyond the Prostate: The Role of Systemic Inflammatory Disorders in Prostate Carcinogenesis

  2025cites this paper
• Posicionamento sobre a Saúde Cardiometabólica ao Longo do Ciclo de Vida da Mulher – 2025

  2025cites this paper
• Protocol for the infant growth and development (iGrowUp) study: the role of food and non-food self-regulation in children’s obesity-related risk

  2025cites this paper
• Life’s essential 8 scores and acute myocardial infarction: Associations with risk, onset delay, and scenario-based preventable fraction estimates

  2025cites this paper
• Pro-inflammatory markers as predictors of arterial thrombosis in aged patients with peripheral arterial disease post revascularization

  2025cites this paper
• Position Statement on Cardiometabolic Health Across the Woman's Life Course – 2025

  2025cites this paper
• Myocardial transcriptomic and proteomic landscapes across the menopausal continuum in a murine model of chemically-induced accelerated ovarian failure.

  2025cites this paper
• Plasma Haptoglobin as A Potential Biomarker for Coronary Artery Disease in Young Hypertensive Adults

  2024cites this paper
• Neutrophil-to-lymphocyte ratio as a predictor of all-cause and cardiovascular mortality in coronary heart disease and hypertensive patients: a retrospective cohort study

  2024cites this paper
• Pentraxin 3 as a marker of development and severity of stable coronary artery disease.

  2024cites this paper
• Prognostic Value of Neutrophil-to-lymphocyte Ratio for Patients with Acute Coronary Syndrome and Obstructive Sleep Apnea

  2024cites this paper
• Mechanistic insight of mitochondrial dysfunctions in cardiovascular diseases with potential biomarkers

  2024cites this paper
• THE ROLE OF INTIMA-MEDIA-THICKNESS, ANKLE BRACHIAL-INDEX, AND INFLAMMATORY BIOCHEMICAL PARAMETERS FOR STROKE RISK PREDICTION: AN UPDATE SYSTEMATIC REVIEW

  2024cites this paper
• The Relationship between the Angiographic Atherosclerotic Burden and the Inflammatory Factors in Diabetic and Non-Diabetic Patients with Coronary Artery Disease

  2023cites this paper
• Biomarkers to monitor the prognosis, disease severity, and treatment efficacy in coronary artery disease

  2023cites this paper
• Systemic Immune-Inflammation Index Predicted Presence and Severity of Coronary Artery Disease

  2022cites this paper
• Association of Serum Pentraxin 3 and High-Sensitivity C-Reactive Protein with Severity of Coronary Stenosis

  2022influential citation
• Current Concepts and Future Applications of Non-Invasive Functional and Anatomical Evaluation of Coronary Artery Disease

  2022cites this paper
• Non-Traditional Predictors for Occurrence and Severity of Premature Atherosclerosis in Acute Coronary Syndrome

  2022cites this paper
• Clinical status of patients with coronary artery disease post COVID-19

  2022cites this paper
• The relation between neutrophil/lymphocyte and platelet/lymphocyte ratios with mortality and limb amputation after acute limb ischaemia

  2021cites this paper
• TNF-α: A Benificial or Harmful Pathogenic Cytokine in Cardiovascular System

  2021cites this paper
• Chronic inflammation and cancer: The role of endothelial dysfunction and vascular inflammation.

  2021cites this paper
• Anti-inflammatory and immunomodulatory effects of rosuvastatin in patients with low-to-moderate cardiovascular risk

  2021cites this paper
• Investigating the relationship between the severity of coronary artery disease and inflammatory factors of MHR, PHR, NHR, and IL-25

  2021cites this paper
• Cancer therapy-related cardiac dysfunction: is endothelial dysfunction at the heart of the matter?

  2021cites this paper
• Nanotechnology in cardiac stem cell therapy: cell modulation, imaging and gene delivery

  2021cites this paper
• Serum Vitamin D and Cardiometabolic Markers: A Comparative Study in Adult Men Based on Body Mass Index

  2021cites this paper
• Atorvastatin Reload Down Regulates TLR-2 Expression and Reduces the Acute Inflammatory Response in Patients Undergoing Percutaneous Coronary Intervention

  2020cites this paper
• "The in ammation link between periodontal disease and coronary atherosclerosis in patients with acute coronary syndromes-case-control study"

  2020cites this paper
• Protocol for iGrow (Infant Growth and Development Study): biopsychosocial predictors of childhood obesity risk at 2 years

  2020cites this paper
• The diagnostic value of circulating microRNAs as biomarkers for coronary artery disease: A meta-analysis

  2020influential citation
• Endothelial Dysfunction in Obesity-Induced Inflammation: Molecular Mechanisms and Clinical Implications

  2020cites this paper
• Correlation studies of miR-126 and inflammatory factors in peripheral blood of patients with coronary heart disease

  2020cites this paper
• The chronic periodontitis in patients with acute coronary syndromes. The inflammation link between periodontal disease and coronary atherosclerosis

  2020cites this paper
• The inflammation link between periodontal disease and coronary atherosclerosis in patients with acute coronary syndromes: case–control study

  2020cites this paper
• Novel Inflammatory Biomarkers as Additional Value to Traditional Risk-factors in Cardiovascular Risk Stratification

  2020cites this paper
• ALT-to-Lymphocyte Ratio as a Predictor of Long-Term Mortality in Patients with Normal Liver Function Presenting Coronary Artery Disease after Undergoing PCI: A Retrospective Cohort Study

  2020cites this paper
• High Plasma sRAGE (Soluble Receptor for Advanced Glycation End Products) Is Associated With Slower Carotid Intima-Media Thickness Progression and Lower Risk for First-Time Coronary Events and Mortality

  2019cites this paper
• Potential Impact of MicroRNA-423 Gene Variability in Coronary Artery Disease.

  2019cites this paper
• Association between Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios and Coronary Artery Calcification Score among Asymptomatic Patients: Data from a Cross-Sectional Study

  2019cites this paper
• Asymmetric Dimethylarginine Predicts One-year Recurrent Cardiovascular Events: Potential Biomarker of “Toxin Syndrome” in Coronary Heart Disease

  2019cites this paper
• Apabetalone (RVX-208) reduces vascular inflammation in vitro and in CVD patients by a BET-dependent epigenetic mechanism

  2019cites this paper
• Interconnection of traditional risk factors with the activity of the inflammatory process and atherosclerosis in patients with psoriatic arthritis

  2019cites this paper
• The Biochemical Markers Associated with the Occurrence of Coronary Spasm

  2019cites this paper
• Correlation of pre‐operative circulating inflammatory cytokines with restenosis and rapid angiographic stenotic progression risk in coronary artery disease patients underwent percutaneous coronary intervention with drug‐eluting stents

  2019cites this paper
• SHARED GENETIC FACTORS OF CONNECTIVE TISSUE-RELATED DISORDERS IN WOMEN

  2019cites this paper
• INFLUENCE OF BETARGIN AND QUERCETIN ON INDICATORS OF CHRONIC SYSTEMIC INFLAMMATION IN PATIENTS WITH CORONARY HEART DISEASE CONCURRENT WITH NON-ALCOHOLIC FATTY LIVER DISEASE

  2019cites this paper
• CXCL9: a biomarker for the coronary slow flow phenomenon in patients with coronary artery disease

  2019cites this paper
• Serum Concentration of hsCRP - Possible Marker for Therapy Evaluation in Left Ventricular Dysfunction with Preserved Ejection Fraction

  2018cites this paper
• Caractérisation des fonctions de transport du cholestérol des sous-types de macrophages M1 et M2 issus de cellules THP-1

  2018influential citation
• Endothelial Dysfunction in Type 2 Diabetes: Targeting Inflammation

  2018cites this paper
• Relationship between serum high sensitivity C‐reactive protein with angiographic severity of coronary artery disease and traditional cardiovascular risk factors

  2018cites this paper
• Comprehensive analysis of predictive factors for rapid angiographic stenotic progression and restenosis risk in coronary artery disease patients underwent percutaneous coronary intervention with drug‐eluting stents implantation

  2018cites this paper
• Design and Synthesis of Aza-/Oxa Heterocycle-Based Conjugates as Novel Anti-Inflammatory Agents Targeting Cyclooxygenase-2

  2018cites this paper
• Serum C‐reactive protein in the prediction of cardiovascular diseases: Overview of the latest clinical studies and public health practice

  2018cites this paper
• Chapter 6 Biomarkers , Obesity , and Cardiovascular Diseases

  2018cites this paper
• Correlation between immunological-inflammatory markers and endothelial disfunction in the early stage of coronary heart disease.

  2018cites this paper
• Unmet Needs in the Pathogenesis and Treatment of Cardiovascular Comorbidities in Chronic Inflammatory Diseases

  2018cites this paper
• TNF-α and IL-6 inhibitors: Conjugates of N-substituted indole and aminophenylmorpholin-3-one as anti-inflammatory agents.

  2017cites this paper
• Novel Biomarkers at Risk Stratification of Diabetes Mellitus Patients

  2017cites this paper
• Correlation and prognostic role of neutrophil to lymphocyte ratio and SYNTAX score in patients with acute myocardial infarction treated with percutaneous coronary intervention: A six-year experience.

  2017cites this paper
• Cadmium exposure is associated with soluble urokinase plasminogen activator receptor, a circulating marker of inflammation and future cardiovascular disease

  2017cites this paper
• Cardiovascular Risk in Early Psychosis: Relationship with Inflammation and Clinical Features 6 Months after Diagnosis

  2017cites this paper
• [Potential protective role of nitric oxide and Hsp70 linked to functional foods in the atherosclerosis].

  2017cites this paper
• Differences in Gene Expression and Gene Associations in Epicardial Fat Compared to Subcutaneous Fat

  2017cites this paper
• Potential protective role of nitric oxide and Hsp70 linked to functional foods in the atherosclerosis

  2017cites this paper
• Pregnancy-associated plasma protein-A (PAPP-A) as a possible biomarker in patients with coronary artery disease

  2017cites this paper
• Cardiac biomarkers in diabetes mellitus: New dawn for risk stratification?

  2017cites this paper
• Factor de necrosis tumoral alfa plasmático en mujeres obesas y no obesas con síndrome de ovarios poliquísticos

  2016cites this paper
• Impacto de la infección con Trypanosoma cruzi y la nutrición sobre la expresión de receptores innatos y parámetros inmuno-metabólicos en un modelo de obesidad.

  2016cites this paper
• Adsorption and conformational modification of fibronectin and fibrinogen adsorbed on hydroxyapatite. A QCM-D study.

  2016cites this paper
• Improving cardiovascular health in Spanish seafarers.

  2016cites this paper
• Neutrophil to Lymphocyte Ratio and Cardiovascular Disease Incidence in HIV-Infected Patients: A Population-Based Cohort Study

  2016cites this paper
• Measuring soluble CD40 ligand: it is a fancy prognostic biomarker in STEMI-patients?

  2016cites this paper
• The Association Between Dental Status and Systemic Lipid Profile and Inflammatory Mediators in Patients After Myocardial Infarction.

  2016cites this paper
• Prognostic value of plasma biomarkers in patients with acute coronary syndrome: a review of advances in the past decade.

  2016cites this paper
• Usefulness of the d-ROMs test for prediction of cardiovascular events.

  2016cites this paper
• Anti-inflammatory, Antithrombotic and Cardiac Remodeling Preventive Effects of Eugenol in Isoproterenol-Induced Myocardial Infarction in Wistar Rat

  2016cites this paper
• Nonclassical human leukocyte antigen (HLA-G, HLA-E, and HLA-F) in coronary artery disease.

  2016cites this paper
• Three Approaches to Modeling Gene‐Environment Interactions in Longitudinal Family Data: Gene‐Smoking Interactions in Blood Pressure

  2016cites this paper
• Biomarkers, Obesity, and Cardiovascular Diseases

  2016cites this paper
• Roles of antibody against oxygenized low density lipoprotein in atherosclerosis: recent advances.

  2015cites this paper
• Cardiovascular Biomarkers in Routine Screening of Diabetic Pati ents

  2015cites this paper
• Koroner arter hastaliğinda risk belirleyici yeni değişkenler

  2015cites this paper
• Cytokines, angiogenic, and antiangiogenic factors and bioactive lipids in preeclampsia.

  2015cites this paper
• Koroner arter hastalığında risk belirleyici yeni parametreler

  2015cites this paper
• Koroner arter hastaliğinda risk belirleyici yeni parametreler

  2015cites this paper